Zurich Insurance (ZURN.SW) traded down -0.58 % during a 24 hours period ending at 09:18 PM Central Europe on Monday 26th. One Zurich Insurance stock can currently be bought for about CHF 619.2 on popular exchanges. Current supply of Zurich Insurance stocks is 151.2 mn. Zurich Insurance has a current market capitalization of CHF 93.5 bn and approximately CHF 147.4 mn worth of Zurich Insurance was traded on exchanges in the last 24 hours. Since last month end, Zurich Insurance has traded 6.77 % up. Simple moving average of last 200 days is at CHF 575.36. The highest price of past 52 weeks was recorded at CHF 627.4 on 10/22/2026. 52 weeks low was at CHF 521 on 03/09/2026.

Summary of the latest news for Zurich Insurance

Zurich Insurance Group AG’s shares have shown notable growth over the past five years, with the stock’s price rising from roughly 404 CHF to 618 CHF, reflecting a substantial percentage increase for long‑term investors. The company’s market capitalization has reached a high valuation, underscoring its strong position within the Swiss market. Although the article does not detail dividend payouts or stock‑split events, it highlights the positive performance of the investment for shareholders over the five‑year period. This performance illustrates Zurich Insurance Group’s resilience and its ability to deliver value to investors amid a dynamic financial environment.

Here is how related stocks have performed in the past 24 hours:

  • Garmin (GRMN) traded down -0.56 % and now trades at USD 292.92. Current market capitalisation for Garmin is USD 56.7 bn. Current price/earnings ratio for Garmin is 30.48.

  • Givaudan (GIVN.SW) traded up 0.45 % and now trades at CHF 3,940. Current market capitalisation for Givaudan is CHF 36.9 bn. Givaudan has a current price to earnings ratio of 38.95.

  • Galderma (GALD.SW) traded up 2.33 % and now trades at CHF 190.9. Current market capitalisation for Galderma is CHF 44.6 bn. Galderma has a current price to earnings ratio of 78.21. Galderma Group AG continues to reinforce its position in the injectable aesthetics market, building on a stable portfolio that includes neuromodulators and dermal fillers. Recent sales figures demonstrate sustained growth, reflecting the company’s established relationships with practitioners and the widespread use of its products. In parallel, the company is exploring new delivery technologies, such as microneedle systems, to enhance precision and patient experience. While competitors like AbbVie expand their own multimodal treatment frameworks, Galderma’s focus remains on integrating proven ingredients with rigorous clinical data and regulatory compliance. The firm’s strategy emphasizes reliable dosing, safe application, and repeatable treatment processes, aiming to maintain its competitive advantage in a market that values both product efficacy and professional integration.

  • Lonza (LONN.SW) traded up 0.57 % and now trades at CHF 634.8. Lonza has a market capitalisation of CHF 44.1 bn. Current price/earnings ratio for Lonza is 57.97.

  • Chubb (CB) traded down -2.43 % and now trades at USD 356.74. Current market capitalisation for Chubb is USD 135.8 bn. Current price/earnings ratio for Chubb is 12.45. A recent retrospective analysis highlighted the performance of Chubb Ltd.’s shares over the past decade. According to a report from a financial news outlet, investors who had placed money in the company’s stock a decade earlier would now own a sizable portfolio, with the value of those shares having risen substantially. The article noted that the shares, which finished a trading day at just over one hundred dollars ten years ago, have appreciated to a higher price at the close of the most recent trading session. This growth reflects the company’s continued market presence, with its market capitalization approaching the hundred‑plus billion dollar range. The piece clarified that the calculation did not account for any share‑splits or dividends that may have occurred during the period.

About Zurich Insurance

The Zurich Insurance Group AG offers insurance-based financial services, providing a range of general and life insurance products and services for various customer segments, including individuals, small businesses, commercial enterprises, mid-sized and large corporations, and multinational companies.